On Monday, Abeona Therapeutics Inc (NASDAQ: ABEO) was -4.23% drop from the session before settling in for the closing price of $4.97. A 52-week range for ABEO has been $3.05 – $8.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -15.07% over the last five years. When this article was written, the company’s average yearly earnings per share was at 20.86%. With a float of $42.86 million, this company’s outstanding shares have now reached $45.64 million.
The firm has a total of 136 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Abeona Therapeutics Inc (ABEO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Abeona Therapeutics Inc stocks. The insider ownership of Abeona Therapeutics Inc is 11.70%, while institutional ownership is 64.23%. The most recent insider transaction that took place on Mar 31 ’25, was worth 119,500. In this transaction Chief Executive Officer of this company sold 25,000 shares at a rate of $4.78, taking the stock ownership to the 1,355,322 shares. Before that another transaction happened on Mar 31 ’25, when Company’s Officer proposed sale 25,000 for $4.78, making the entire transaction worth $119,560.
Abeona Therapeutics Inc (ABEO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 70.45% during the next five years compared to 47.21% growth over the previous five years of trading.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
You can see what Abeona Therapeutics Inc (ABEO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -0.10 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Analysing the last 5-days average volume posted by the [Abeona Therapeutics Inc, ABEO], we can find that recorded value of 0.55 million was better than the volume posted last year of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 17.32%. Additionally, its Average True Range was 0.26.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 3.81%, which indicates a significant decrease from 8.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.67% in the past 14 days, which was lower than the 42.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.39, while its 200-day Moving Average is $5.54. Now, the first resistance to watch is $4.92. This is followed by the second major resistance level at $5.08. The third major resistance level sits at $5.20. If the price goes on to break the first support level at $4.64, it is likely to go to the next support level at $4.52. Should the price break the second support level, the third support level stands at $4.36.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
There are 48,534K outstanding shares of the company, which has a market capitalization of 231.02 million. As of now, sales total 0 K while income totals -63,730 K. Its latest quarter income was 0 K while its last quarter net income were -9,290 K.
